Northern Oak Wealth Management Inc Amgen Inc Transaction History

Northern Oak Wealth Management Inc

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 16, 2022	BUY	$230.71 - $256.74 $41,527 - $46,213	180 New	180 $44,000
Q1 2022 May 24, 2022	SELL	$219.27 - $242.57 $43,854 - $48,514	-200 Closed	0 $0
Q4 2021 Feb 16, 2022	BUY	$198.88 - $227.6 $2,784 - $3,186	14 Added 7.53%	200 $45,000
Q4 2020 Feb 16, 2021	BUY	$216.38 - $257.67 $1,298 - $1,546	6 Added 3.33%	186 $43,000
Q3 2019 Oct 31, 2019	SELL	$174.11 - $208.62 $69,644 - $83,448	-400 Reduced 68.97%	180 $34,000
Q2 2019 Jul 30, 2019	SELL	$166.7 - $195.41 $33,340 - $39,082	-200 Reduced 25.64%	580 $0
Q4 2018 Feb 14, 2019	BUY	$178.4 - $208.25 $107,040 - $124,950	600 Added 333.33%	780 $151,000
Q1 2018 May 11, 2018	SELL	$169.43 - $198.0 $128,766 - $150,480	-760 Reduced 80.85%	180 $0
Q4 2017 Feb 16, 2018	BUY	$168.79 - $188.59 $158,662 - $177,274	940	940 $0

3,075

417M

7.19M

6.28M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $169B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Northern Oak Wealth Management Inc, based on Form 13F filings with the SEC.

Stay updated on Northern Oak Wealth Management Inc with notifications on news.